In vitro digestion-assisted development of a β-cryptoxanthin-rich functional beverage; in vivo validation using systemic response and faecal content
•Different lipid emulsions modify the in vitro bioaccessibility of β-Cx.•A food matrix containing milkfat globule membrane is an adequate delivery system for β-Cx.•In vitro digestion is a suitable approach to develop functional foods but not fully predictive.•In vivo serum response does not predict...
Gespeichert in:
| Veröffentlicht in: | Food chemistry 2016-10, Vol.208, p.18-25 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 25 |
|---|---|
| container_issue | |
| container_start_page | 18 |
| container_title | Food chemistry |
| container_volume | 208 |
| creator | Hernández-Alvarez, E. Blanco-Navarro, I. Pérez-Sacristán, B. Sánchez-Siles, L.M. Granado-Lorencio, F. |
| description | •Different lipid emulsions modify the in vitro bioaccessibility of β-Cx.•A food matrix containing milkfat globule membrane is an adequate delivery system for β-Cx.•In vitro digestion is a suitable approach to develop functional foods but not fully predictive.•In vivo serum response does not predict reliably the availability of carotenoids at the colon.
Bioavailability of carotenoids is low and significant amounts reach the colon where they may be biologically active. We aimed to optimize a previously developed beverage designed to improve cardiovascular and bone remodelling markers in post-menopausal women. By assessing different lipid emulsions (soy lecithin, milkfat globule membrane (MFGM) and olive oil) on the in vitro bioaccessibility of β-Cryptoxanthin and phytosterols, a MFGM containing beverage was selected and resulted stable over time (recovery >95%) under in vitro digestion and simulated anaerobic conditions. This beverage was tested in a randomized human trial (n=38) by evaluating systemic response and the colonic availability of β-Cryptoxanthin. Consumption for six weeks provoked an increment in serum β-Cryptoxanthin of 38.9μg/dl (CI 95%; 31.0, 46.8; p |
| doi_str_mv | 10.1016/j.foodchem.2016.03.119 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1786524743</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0308814616305040</els_id><sourcerecordid>1786524743</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-b817895c381dcdfc4e445ead6b06ca011ed4a28e668705e563821ff3aa8377f13</originalsourceid><addsrcrecordid>eNqFkcFu1DAURS0EokPLL1Reskmw48T2iA2oKm2lSmzo2vLYzzMeJXawk4j5EH6ED-GbcDQtW1ZPT-_ce_V0EbqmpKaE8o_H2sVozQGGuil7TVhN6fYV2lApWCWIaF6jDWFEVpK2_AK9y_lICCmsfIsuGkFZI-l2g349BLz4KUVs_R7y5GOodM4-T2CxhQX6OA4QJhwd1vjP78qk0zjFnzpMBx-q5M0BuzmYVah7vCuKpPfwCfvVd4l40b23ej3jOfuwx_lUvAdvcII8xpAB62Cx02CK3sQwlbQr9MbpPsP753mJnr7efr-5rx6_3T3cfHmsDONyqnaSCrntDJPUGutMC23bgbZ8R7jRhFKwrW4kcC4F6aDjTDbUOaa1ZEI4yi7Rh7PvmOKPubyvBp8N9L0OEOesij3vmla0rKD8jJoUc07g1Jj8oNNJUaLWStRRvVSi1koUYapUUoTXzxnzbgD7T_bSQQE-nwEony4eksrGQzBgfQIzKRv9_zL-Am-hpT8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1786524743</pqid></control><display><type>article</type><title>In vitro digestion-assisted development of a β-cryptoxanthin-rich functional beverage; in vivo validation using systemic response and faecal content</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Hernández-Alvarez, E. ; Blanco-Navarro, I. ; Pérez-Sacristán, B. ; Sánchez-Siles, L.M. ; Granado-Lorencio, F.</creator><creatorcontrib>Hernández-Alvarez, E. ; Blanco-Navarro, I. ; Pérez-Sacristán, B. ; Sánchez-Siles, L.M. ; Granado-Lorencio, F.</creatorcontrib><description>•Different lipid emulsions modify the in vitro bioaccessibility of β-Cx.•A food matrix containing milkfat globule membrane is an adequate delivery system for β-Cx.•In vitro digestion is a suitable approach to develop functional foods but not fully predictive.•In vivo serum response does not predict reliably the availability of carotenoids at the colon.
Bioavailability of carotenoids is low and significant amounts reach the colon where they may be biologically active. We aimed to optimize a previously developed beverage designed to improve cardiovascular and bone remodelling markers in post-menopausal women. By assessing different lipid emulsions (soy lecithin, milkfat globule membrane (MFGM) and olive oil) on the in vitro bioaccessibility of β-Cryptoxanthin and phytosterols, a MFGM containing beverage was selected and resulted stable over time (recovery >95%) under in vitro digestion and simulated anaerobic conditions. This beverage was tested in a randomized human trial (n=38) by evaluating systemic response and the colonic availability of β-Cryptoxanthin. Consumption for six weeks provoked an increment in serum β-Cryptoxanthin of 38.9μg/dl (CI 95%; 31.0, 46.8; p<0.001). In faeces, free β-Cryptoxanthin, tentatively identified β-Cryptoxanthin esters and the ratio cis-/trans-β-carotene approached the profile in the beverage and after in vitro digestion but it was different from serum. In conclusion, in vitro digestion-assisted approach appears adequate to develop functional foods although in vivo validation should consider both systemic response and the availability at the colon.</description><identifier>ISSN: 0308-8146</identifier><identifier>EISSN: 1873-7072</identifier><identifier>DOI: 10.1016/j.foodchem.2016.03.119</identifier><identifier>PMID: 27132819</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>beta Carotene - analysis ; Beta-Cryptoxanthin - analysis ; Beverages ; Biological Availability ; Carotenoids - analysis ; Digestion - physiology ; Faecal content ; Female ; Functional foods ; Human study ; Humans ; In vitro digestion ; Middle Aged ; Phytosterols - analysis ; β-Cryptoxanthin</subject><ispartof>Food chemistry, 2016-10, Vol.208, p.18-25</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-b817895c381dcdfc4e445ead6b06ca011ed4a28e668705e563821ff3aa8377f13</citedby><cites>FETCH-LOGICAL-c368t-b817895c381dcdfc4e445ead6b06ca011ed4a28e668705e563821ff3aa8377f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.foodchem.2016.03.119$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27132819$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hernández-Alvarez, E.</creatorcontrib><creatorcontrib>Blanco-Navarro, I.</creatorcontrib><creatorcontrib>Pérez-Sacristán, B.</creatorcontrib><creatorcontrib>Sánchez-Siles, L.M.</creatorcontrib><creatorcontrib>Granado-Lorencio, F.</creatorcontrib><title>In vitro digestion-assisted development of a β-cryptoxanthin-rich functional beverage; in vivo validation using systemic response and faecal content</title><title>Food chemistry</title><addtitle>Food Chem</addtitle><description>•Different lipid emulsions modify the in vitro bioaccessibility of β-Cx.•A food matrix containing milkfat globule membrane is an adequate delivery system for β-Cx.•In vitro digestion is a suitable approach to develop functional foods but not fully predictive.•In vivo serum response does not predict reliably the availability of carotenoids at the colon.
Bioavailability of carotenoids is low and significant amounts reach the colon where they may be biologically active. We aimed to optimize a previously developed beverage designed to improve cardiovascular and bone remodelling markers in post-menopausal women. By assessing different lipid emulsions (soy lecithin, milkfat globule membrane (MFGM) and olive oil) on the in vitro bioaccessibility of β-Cryptoxanthin and phytosterols, a MFGM containing beverage was selected and resulted stable over time (recovery >95%) under in vitro digestion and simulated anaerobic conditions. This beverage was tested in a randomized human trial (n=38) by evaluating systemic response and the colonic availability of β-Cryptoxanthin. Consumption for six weeks provoked an increment in serum β-Cryptoxanthin of 38.9μg/dl (CI 95%; 31.0, 46.8; p<0.001). In faeces, free β-Cryptoxanthin, tentatively identified β-Cryptoxanthin esters and the ratio cis-/trans-β-carotene approached the profile in the beverage and after in vitro digestion but it was different from serum. In conclusion, in vitro digestion-assisted approach appears adequate to develop functional foods although in vivo validation should consider both systemic response and the availability at the colon.</description><subject>beta Carotene - analysis</subject><subject>Beta-Cryptoxanthin - analysis</subject><subject>Beverages</subject><subject>Biological Availability</subject><subject>Carotenoids - analysis</subject><subject>Digestion - physiology</subject><subject>Faecal content</subject><subject>Female</subject><subject>Functional foods</subject><subject>Human study</subject><subject>Humans</subject><subject>In vitro digestion</subject><subject>Middle Aged</subject><subject>Phytosterols - analysis</subject><subject>β-Cryptoxanthin</subject><issn>0308-8146</issn><issn>1873-7072</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAURS0EokPLL1Reskmw48T2iA2oKm2lSmzo2vLYzzMeJXawk4j5EH6ED-GbcDQtW1ZPT-_ce_V0EbqmpKaE8o_H2sVozQGGuil7TVhN6fYV2lApWCWIaF6jDWFEVpK2_AK9y_lICCmsfIsuGkFZI-l2g349BLz4KUVs_R7y5GOodM4-T2CxhQX6OA4QJhwd1vjP78qk0zjFnzpMBx-q5M0BuzmYVah7vCuKpPfwCfvVd4l40b23ej3jOfuwx_lUvAdvcII8xpAB62Cx02CK3sQwlbQr9MbpPsP753mJnr7efr-5rx6_3T3cfHmsDONyqnaSCrntDJPUGutMC23bgbZ8R7jRhFKwrW4kcC4F6aDjTDbUOaa1ZEI4yi7Rh7PvmOKPubyvBp8N9L0OEOesij3vmla0rKD8jJoUc07g1Jj8oNNJUaLWStRRvVSi1koUYapUUoTXzxnzbgD7T_bSQQE-nwEony4eksrGQzBgfQIzKRv9_zL-Am-hpT8</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Hernández-Alvarez, E.</creator><creator>Blanco-Navarro, I.</creator><creator>Pérez-Sacristán, B.</creator><creator>Sánchez-Siles, L.M.</creator><creator>Granado-Lorencio, F.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20161001</creationdate><title>In vitro digestion-assisted development of a β-cryptoxanthin-rich functional beverage; in vivo validation using systemic response and faecal content</title><author>Hernández-Alvarez, E. ; Blanco-Navarro, I. ; Pérez-Sacristán, B. ; Sánchez-Siles, L.M. ; Granado-Lorencio, F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-b817895c381dcdfc4e445ead6b06ca011ed4a28e668705e563821ff3aa8377f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>beta Carotene - analysis</topic><topic>Beta-Cryptoxanthin - analysis</topic><topic>Beverages</topic><topic>Biological Availability</topic><topic>Carotenoids - analysis</topic><topic>Digestion - physiology</topic><topic>Faecal content</topic><topic>Female</topic><topic>Functional foods</topic><topic>Human study</topic><topic>Humans</topic><topic>In vitro digestion</topic><topic>Middle Aged</topic><topic>Phytosterols - analysis</topic><topic>β-Cryptoxanthin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hernández-Alvarez, E.</creatorcontrib><creatorcontrib>Blanco-Navarro, I.</creatorcontrib><creatorcontrib>Pérez-Sacristán, B.</creatorcontrib><creatorcontrib>Sánchez-Siles, L.M.</creatorcontrib><creatorcontrib>Granado-Lorencio, F.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Food chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hernández-Alvarez, E.</au><au>Blanco-Navarro, I.</au><au>Pérez-Sacristán, B.</au><au>Sánchez-Siles, L.M.</au><au>Granado-Lorencio, F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro digestion-assisted development of a β-cryptoxanthin-rich functional beverage; in vivo validation using systemic response and faecal content</atitle><jtitle>Food chemistry</jtitle><addtitle>Food Chem</addtitle><date>2016-10-01</date><risdate>2016</risdate><volume>208</volume><spage>18</spage><epage>25</epage><pages>18-25</pages><issn>0308-8146</issn><eissn>1873-7072</eissn><abstract>•Different lipid emulsions modify the in vitro bioaccessibility of β-Cx.•A food matrix containing milkfat globule membrane is an adequate delivery system for β-Cx.•In vitro digestion is a suitable approach to develop functional foods but not fully predictive.•In vivo serum response does not predict reliably the availability of carotenoids at the colon.
Bioavailability of carotenoids is low and significant amounts reach the colon where they may be biologically active. We aimed to optimize a previously developed beverage designed to improve cardiovascular and bone remodelling markers in post-menopausal women. By assessing different lipid emulsions (soy lecithin, milkfat globule membrane (MFGM) and olive oil) on the in vitro bioaccessibility of β-Cryptoxanthin and phytosterols, a MFGM containing beverage was selected and resulted stable over time (recovery >95%) under in vitro digestion and simulated anaerobic conditions. This beverage was tested in a randomized human trial (n=38) by evaluating systemic response and the colonic availability of β-Cryptoxanthin. Consumption for six weeks provoked an increment in serum β-Cryptoxanthin of 38.9μg/dl (CI 95%; 31.0, 46.8; p<0.001). In faeces, free β-Cryptoxanthin, tentatively identified β-Cryptoxanthin esters and the ratio cis-/trans-β-carotene approached the profile in the beverage and after in vitro digestion but it was different from serum. In conclusion, in vitro digestion-assisted approach appears adequate to develop functional foods although in vivo validation should consider both systemic response and the availability at the colon.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27132819</pmid><doi>10.1016/j.foodchem.2016.03.119</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0308-8146 |
| ispartof | Food chemistry, 2016-10, Vol.208, p.18-25 |
| issn | 0308-8146 1873-7072 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1786524743 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | beta Carotene - analysis Beta-Cryptoxanthin - analysis Beverages Biological Availability Carotenoids - analysis Digestion - physiology Faecal content Female Functional foods Human study Humans In vitro digestion Middle Aged Phytosterols - analysis β-Cryptoxanthin |
| title | In vitro digestion-assisted development of a β-cryptoxanthin-rich functional beverage; in vivo validation using systemic response and faecal content |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T09%3A51%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20digestion-assisted%20development%20of%20a%20%CE%B2-cryptoxanthin-rich%20functional%20beverage;%20in%20vivo%20validation%20using%20systemic%20response%20and%20faecal%20content&rft.jtitle=Food%20chemistry&rft.au=Hern%C3%A1ndez-Alvarez,%20E.&rft.date=2016-10-01&rft.volume=208&rft.spage=18&rft.epage=25&rft.pages=18-25&rft.issn=0308-8146&rft.eissn=1873-7072&rft_id=info:doi/10.1016/j.foodchem.2016.03.119&rft_dat=%3Cproquest_cross%3E1786524743%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1786524743&rft_id=info:pmid/27132819&rft_els_id=S0308814616305040&rfr_iscdi=true |